Kite Pharma Says Cancer Drug KTE-C19 Showing Great Promise

Eight patients with aggressive non-Hodgkin’s lymphoma treated with Kite Pharma Inc.‘s cancer drug were in complete remission and four others in partial remission, the company announced Monday. Company More...